Peculiarities of lipoperoxidation processes in chronic obstructive pulmonary disease associated with multiple myeloma

O. Smirnova (Krasnoyarsk, Russian Federation)

Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Smirnova (Krasnoyarsk, Russian Federation). Peculiarities of lipoperoxidation processes in chronic obstructive pulmonary disease associated with multiple myeloma. 822

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Features of the chemiluminescent activity of neutrophils in chronic obstructive pulmonary disease associated with multiple myeloma
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020


Regulation disorders of pulmonary lipid metabolism in chronic obstructive pulmonary disease
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019


Erythropoietin dysregulation in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008


Oxidant metabolism in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 14S-27S
Year: 2003



Systemic inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 5S-13S
Year: 2003



Immunological profiling of chronic obstructive airways disease and idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002

Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006

Evaluation of oxidative stress on pathogenesis and severity of chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008

Hormonal changes and catabolic/anabolic imbalance in chronic obstructive pulmonary disease and their importance for pulmonary cachexia
Source: Eur Respir J 2002; 20: Suppl. 38, 202s
Year: 2002

Cutaneous vascular spiders are associated with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases
Year: 2009


Peculiarities of cardiac rhythm in stable chronic obstructive pulmonary disease
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017


Clinical-immunological efficiency of immunomodulation in chronic obstructive pulmonary deceases
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

The role of inflamatory markers in obstructive pulmonary disease
Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Year: 2012

Role of oxidative-antioxidative imbalance and thyroid hormones in stable chronic obstructive pulmonary disease
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009


Anemia in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012

Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012


Effects of severity of chronic obstructive pulmonary disease on thyroid function
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005

Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Pathophysiological features of chronic obstructive pulmonary disease in obese patients
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017